Multidrug-resistant bacteria in ICU: fact or myth

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Microbiology

Background:

• Antimicrobial resistance (AMR) is a significant and increasing threat in intensive care units (ICUs) worldwide.
• The prevalence and characteristics of AMR, especially Gram-negative multidrug-resistant organisms (MDROs), exhibit substantial geographical variation.
• ICU patients face elevated risks of MDRO infections due to multiple co-existing risk factors.

Purpose of the Study:

• To review current literature on antimicrobial resistance in ICUs.
• To determine if the increasing prevalence of AMR in ICUs is a myth or a reality.
• To discuss the challenges and potential solutions for combating AMR in the ICU setting.

Main Methods:

• Literature review of recent studies on antimicrobial resistance in ICUs.
• Analysis of geographical variations in the prevalence of multidrug-resistant organisms (MDROs).
• Identification of risk factors for MDRO infections in ICU patients.

Main Results:

• Antimicrobial resistance (AMR), particularly from Gram-negative MDROs, represents a major global challenge in ICUs.
• Significant geographical disparities exist in MDRO prevalence, necessitating consideration of local epidemiology.
• Effective solutions involve stringent infection prevention and control measures to minimize cross-transmission and reduce antimicrobial exposure.

Conclusions:

• Antimicrobial resistance (AMR) is an established reality in most ICUs globally, though its extent varies considerably.
• Implementing robust infection prevention and control strategies is crucial.
• Appropriate antimicrobial stewardship is fundamental to mitigating the development and spread of AMR.